Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2013-06-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Tolerability Assessment of a Probiotic Dietary Supplement
NCT04044144
Probiotics and Non-Organic Gastrointestinal Improvement
NCT07081100
Effect of a Nutritional Supplement on Gut Microbiota in Adults
NCT06611215
The Effect of Probiotics on the Improvement of Digestive Function and Well-being in the Elderly
NCT06648590
Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
NCT04281407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Nutritional Supplement
2 servings a day
Oral Nutritional Supplement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Nutritional Supplement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) \> 20 but \< 35.
Exclusion Criteria
* History of diabetes
* Antibiotic use within 1 week prior to enrollment
* Undergone major surgery less than 3 months prior to enrollment.
* Current active malignant disease or was treated within the last 6 months for cancer.
* Immunodeficiency disorder.
* Myocardial infarction within the last 3 months.
* Chronic obstructive pulmonary disease (COPD).
* Allergy to any of the ingredients in the study product.
* Obstruction of the gastrointestinal tract or other major gastrointestinal disease.
* Dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder.
* Unintentional weight loss or weight gain ≥ 5% in last 4 weeks.
* Taking medications/dietary supplements/substances that could profoundly modulate metabolism or affect GI motility.
60 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey Nelson, PhD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biofortis Sas
Saint-Herblain, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BL16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.